Milbemycin oxime

Star0

DB11531ExperimentalVet approvedSmall molecule

Milbemycin oxime: Overview.

Mechanism: Pharmacologically active on ABC transporters
Curator reviewed
Formula / weight: C₆₃H₈₈N₂O₁₄ · 1097.397 g/mol (avg)
Code names: CGA-179246

Resolves to

Compound

UNII0502PUN0GTCAS129496-10-2

Clinical / RWD

RxNorm68730

Structure

InChIKeyCKVMAPHTVCTEMM-ALPQRHTBSA-NSMILES

[H][C@@]12OC\C3=C/C=C/[C@H](C)C\C(C)=C\C[C@]4([H])C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C)O5)O4)OC(=O)[C@]([H])(C=C(C)\C1=N\O)[C@@]23O.[H][C@@]12OC\C3=C/C=C/[C@H](C)C\C(C)=C\C[C@]4([H])C[C@@H](C[C@]5(CC[C@H](C)[C@@H](CC)O5)O4)OC(=O)[C@]([H])(C=C(C)\C1=N\O)[C@@]23O

What you can answer from here — as of October 10, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

10Marketed productsAcross 1 country and 2 labellers

1+ReferenceStructured and connected to the statements they support

Which companies are running trials of Milbemycin oxime, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account